4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001209191-22-032383
Chief Executive Officer sold 18,415 shares at $0.77 ($14,180)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2022-05-25 | Sale | −18,415 | $0.77 | $14,180 | 3,976,894 | D |
| Open-market sales · 18,415 sh · avg $0.77 · $14,180 | |||||||
Loading xslF345X03/doc4.xml…